These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7989722)

  • 1. Analysis of the hepatitis C virus genome in patients with anti-LKM-1 autoantibodies.
    Gerotto M; Pontisso P; Giostra F; Francesconi R; Muratori L; Ballardini G; Lenzi M; Tisminetzky S; Bianchi FB; Baralle FB
    J Hepatol; 1994 Aug; 21(2):273-6. PubMed ID: 7989722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2.
    Michitaka K; Durazzo M; Tillmann HL; Walker D; Philipp T; Manns MP
    Gastroenterology; 1994 Jun; 106(6):1603-10. PubMed ID: 8194708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and western blot and their association with anti-HCV and HCV-RNA.
    Seelig R; Renz M; Bünger G; Schröter H; Seelig HP
    Clin Exp Immunol; 1993 Jun; 92(3):373-80. PubMed ID: 8390333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders.
    Todros L; Touscoz G; D'Urso N; Durazzo M; Albano E; Poli G; Baldi M; Rizzetto M
    J Hepatol; 1991 Jul; 13(1):128-31. PubMed ID: 1655868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-GOR and hepatitis C virus in autoimmune liver diseases.
    Michel G; Ritter A; Gerken G; Meyer zum Büschenfelde KH; Decker R; Manns MP
    Lancet; 1992 Feb; 339(8788):267-9. PubMed ID: 1346282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.
    Muratori L; Lenzi M; Ma Y; Cataleta M; Mieli-Vergani G; Vergani D; Bianchi FB
    Gut; 1995 Sep; 37(3):406-12. PubMed ID: 7590439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low hepatitis C viremia levels in patients with anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis.
    Giostra F; Manzin A; Lenzi M; Francesconi R; Solforosi L; Manotti P; Muratori L; Zauli D; Clementi M; Bianchi FB
    J Hepatol; 1996 Oct; 25(4):433-8. PubMed ID: 8912141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis.
    Miyakawa H; Kitazawa E; Abe K; Kawaguchi N; Fuzikawa H; Kikuchi K; Kako M; Komatsu T; Hayashi N; Kiyosawa K
    J Gastroenterol; 1997 Dec; 32(6):769-76. PubMed ID: 9430015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary and secondary liver/kidney microsomal autoantibody response following infection with hepatitis C virus.
    Mackie FD; Peakman M; Yun M; Sallie R; Smith H; Davies ET; Mieli-Vergani G; Vergani D
    Gastroenterology; 1994 Jun; 106(6):1672-5. PubMed ID: 8194716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of autoantibody and its relationship with genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection.
    Kirdar S; Sener AG; Cengİz M; Aydin N
    APMIS; 2016 Nov; 124(11):979-984. PubMed ID: 27670736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-GOR in hepatitis D: specific association with hepatitis C virus superinfection.
    Durazzo M; Michel G; Philipp T; Braun HB; Luttig B; Rizzetto M; Manns M
    Int J Clin Lab Res; 1994; 24(4):227-9. PubMed ID: 7894050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes.
    Giannini C; Thiers V; Nousbaum JB; Stuyver L; Maertens G; Bréchot C
    J Hepatol; 1995 Sep; 23(3):246-53. PubMed ID: 8550987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis B or C virus infection in patients with fulminant viral hepatitis. An analysis using polymerase chain reaction.
    Inokuchi K; Nakata K; Hamasaki K; Daikoku M; Nakao K; Kato Y; Yatsuhashi H; Koga M; Yano M; Nagataki S
    J Hepatol; 1996 Mar; 24(3):258-64. PubMed ID: 8778190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.
    Ma Y; Peakman M; Lobo-Yeo A; Wen L; Lenzi M; Gäken J; Farzaneh F; Mieli-Vergani G; Bianchi FB; Vergani D
    Clin Exp Immunol; 1994 Jul; 97(1):94-9. PubMed ID: 8033426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of genotype B and C hepatitis B virus-induced chronic hepatitis in relation to the basic core promoter and precore mutations.
    Watanabe K; Takahashi T; Takahashi S; Okoshi S; Ichida T; Aoyagi Y
    J Gastroenterol Hepatol; 2005 Mar; 20(3):441-9. PubMed ID: 15740490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients.
    Kitazawa E; Igarashi T; Kawaguchi N; Matsushima H; Kawashima Y; Hankins RW; Miyakawa H
    J Autoimmun; 2001 Nov; 17(3):243-9. PubMed ID: 11712862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence, clinical features and response to antiviral therapy of patients with chronic hepatitis C who are seropositive for liver-kidney microsome type 1 antibodies.
    Monti V; Aghemo A; Rumi MG; Donato MF; Del Ninno E; Colombo M
    Antivir Ther; 2005; 10(6):715-20. PubMed ID: 16218170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.